Agenda
Below you find the agenda. All the presentations will be sent live on the conference days. You can already add presentations to your calendar, you will then receive a reminder by email 15 minutes before the presentation start - click on the presentation and press "Add".
To join a presentation on the conference day, please click on the slot and press “Check in”.
Oxthera
Oxthera, Matthew Gantz (CEO)
Thursday September 3, 2020 14:30 - 15:00 CEST Room 1
Arjo
Arjo, Daniel Fäldt (CFO)
Thursday September 3, 2020 13:00 - 13:30 CEST Room 1
Midsona
Midsona, Peter Åsberg (CEO)
Thursday September 3, 2020 11:30 - 12:00 CEST Room 1
Probi
Probi, Henrik Lundkvist (CFO), Tom Rönnlund (CEO)
Thursday September 3, 2020 14:00 - 14:30 CEST Room 1
Asarina Pharma
Asarina Pharma, Peter Nordkild (CEO)
Wednesday September 2, 2020 15:00 - 15:30 CEST Room 2
Orexo
Orexo, Nikolaj Sörensen
Thursday September 3, 2020 13:00 - 13:30 CEST Room 2
Herantis Pharma
Herantis, Craig Cook (CEO)
Thursday September 3, 2020 16:00 - 16:30 CEST Room 2
Corline Biomedical
Corline Biomedical, Henrik Nittmar (CEO)
Wednesday September 2, 2020 11:00 - 11:30 CEST Room 2
PCI Biotech
PCI Biotech, Per Walday (Chief Executive Officer)
Thursday September 3, 2020 11:00 - 11:30 CEST Room 2
Infant Bacterial Therapeutics
Infant Bacterial Therapeutics, Staffan Strömberg (CEO)
Thursday September 3, 2020 13:30 - 14:00 CEST Room 2
BioArctic
BioArctic, Gunilla Osswald (CEO)
Thursday September 3, 2020 14:00 - 14:30 CEST Room 2
Surgical Science
Surgical Science, Gisli Hennermark (CEO)
Thursday September 3, 2020 13:30 - 14:00 CEST Room 1
Nordic Nanovector
Nordic Nanovector, Lars Nieba (Interim CEO)
Thursday September 3, 2020 15:00 - 15:30 CEST Room 2
Raysearch
Raysearch Laboratories, Johan Löf (CEO)
Thursday September 3, 2020 10:30 - 11:00 CEST Room 1
Cantargia
Cantargia, Göran Forsberg (CEO)
Thursday September 3, 2020 12:30 - 13:00 CEST Room 2
Getinge
Getinge, Lars Mattsson (Head of IR), Mattias Perjos (President & CEO)
Thursday September 3, 2020 09:30 - 10:00 CEST Room 1
Elekta
Elekta, Cecilia Ketels (Head of Investor Relations)
Thursday September 3, 2020 12:30 - 13:00 CEST Room 1
Gentian Diagnostics
Gentian Diagnostics, Hilja Ibert (CEO)
Wednesday September 2, 2020 13:00 - 13:30 CEST Room 2
Xbrane Biopharma
Xbrane Biopharma, Martin Åmark (CEO & Head of IR)
Thursday September 3, 2020 10:30 - 11:00 CEST Room 2
Recipharm
Thomas Eldered (President and CEO)
Thursday September 3, 2020 16:00 - 16:30 CEST Room 1
Bio-Works
Bio-Works, Jonathan Royce (CEO)
Wednesday September 2, 2020 15:30 - 16:00 CEST Room 2
Ascelia Pharma
Ascelia Pharma, Magnus Corfitzen (CEO)
Wednesday September 2, 2020 09:30 - 10:00 CEST Room 2
Biogaia
BioGaia, Isabelle Ducellier (CEO)
Thursday September 3, 2020 08:30 - 09:00 CEST Room 1
CellaVision
CellaVision, Maria Morin (VP HR & Corporate Communications)
Wednesday September 2, 2020 16:00 - 16:30 CEST Room 1
Targovax
Targovax, Torbjørn Furuseth (CFO )
Wednesday September 2, 2020 11:30 - 12:00 CEST Room 2
IRLAB Therapeutics
IRLAB Therapeutics, Nicholas Waters (CEO)
Thursday September 3, 2020 15:30 - 16:00 CEST Room 1
Vicore Pharma
Vicore Pharma, Carl-Johan Dalsgaard (CEO)
Wednesday September 2, 2020 12:30 - 13:00 CEST Room 2
Sobi
Sobi, Henrik Stenqvist (CFO )
Thursday September 3, 2020 08:30 - 09:00 CEST Room 2
Mentice
Mentice, Henrik Storm, Göran Malmberg (CEO)
Thursday September 3, 2020 10:00 - 10:30 CEST Room 1
Camurus
Camurus, Fredrik Tiberg (President & CEO)
Wednesday September 2, 2020 14:30 - 15:00 CEST Room 2
BerGenBio
BergenBio, Richard Godfrey
Thursday September 3, 2020 11:30 - 12:00 CEST Room 2
Boule Diagnostics
Boule Diagnostics, Jesper Söderqvist (CEO)
Thursday September 3, 2020 11:00 - 11:30 CEST Room 1
Intervacc
Intervacc, Andreas Andersson (CEO)
Thursday September 3, 2020 09:30 - 10:00 CEST Room 2
Alligator Bioscience
Alligator Bioscience, Per Norlén (CEO)
Wednesday September 2, 2020 09:00 - 09:30 CEST Room 2
Immunovia
Immunovia, Mats Grahn (CEO)
Wednesday September 2, 2020 16:00 - 16:30 CEST Room 2
Isofol
Isofol Medical, Jarl Ulf Jungnelius (CEO)
Thursday September 3, 2020 10:00 - 10:30 CEST Room 2
Xvivo Perfusion
Xvivo Perfusion, Dag Andersson (CEO)
Wednesday September 2, 2020 15:30 - 16:00 CEST Room 1
Bioinvent
Bioinvent, Martin Welschof (CEO)
Wednesday September 2, 2020 10:30 - 11:00 CEST Room 2
Biovica
Biovica, Anders Rylander (CEO)
Thursday September 3, 2020 14:30 - 15:00 CEST Room 2
Medistim
Medistim, Thomas Jakobsen (CFO ), Kari Krogstad (President and CEO )
Wednesday September 2, 2020 14:30 - 15:00 CEST Room 1
IRRAS
IRRAS, Will Martin (President & CCO)
Wednesday September 2, 2020 15:00 - 15:30 CEST Room 1
Swedencare
Swedencare, Håkan Lagerberg (CEO)
Wednesday September 2, 2020 11:00 - 11:30 CEST Room 1
Cellink
Cellink, Erik Gatenholm (CEO & Co-Founder)
Thursday September 3, 2020 09:00 - 09:30 CEST Room 1
Sedana Medical
Sedana Medical, Christer Ahlberg (CEO)
Thursday September 3, 2020 15:00 - 15:30 CEST Room 1
PledPharma
PledPharma, Mervin Nicklas Westerholm (CEO & President)
Wednesday September 2, 2020 10:00 - 10:30 CEST Room 2
Bonesupport
Bonesupport, Emil Billbäck (CEO)
Wednesday September 2, 2020 10:00 - 10:30 CEST Room 1
Genovis
Genovis, Fredrik Olsson (CEO)
Wednesday September 2, 2020 13:30 - 14:00 CEST Room 1
X-Spray Pharma
X-Spray Pharma, Per Andersson (CEO)
Thursday September 3, 2020 09:00 - 09:30 CEST Room 2
Carasent
Carasent, Niclas Hugosson (Business Development), Johan Lindqvist (COB Carasent ASA), Dennis Höjer (MD Evimeria EMR AB)
Wednesday September 2, 2020 12:30 - 13:00 CEST Room 1
Iconovo
Iconovo, Johan Wäborg (CEO)
Wednesday September 2, 2020 13:00 - 13:30 CEST Room 1
Q-Linea
Q-Linea, Jonas Jarvius (CEO)
Wednesday September 2, 2020 09:00 - 09:30 CEST Room 1
Oncopeptides
Oncopeptides, Marty Duvall (CEO), Jacob Lindberg (CSO)
Wednesday September 2, 2020 14:00 - 14:30 CEST Room 2
SyntheticMR
SyntheticMR, Ulrik Harrysson (CEO)
Wednesday September 2, 2020 09:30 - 10:00 CEST Room 1
Vitrolife
Vitrolife, Thomas Axelsson (CEO)
Wednesday September 2, 2020 08:30 - 09:00 CEST Room 1
Hansa Biopharma
Hansa Biopharma, Sören Tulstrup (CEO)
Thursday September 3, 2020 15:30 - 16:00 CEST Room 2
Introduction by Pareto Securities
Pareto Securities, Ingeborg Magnusson, Matilda Karlsson, Dan Akschuti (Equity Research)
Wednesday September 2, 2020 08:00 - 08:30 CEST Room 1
Arctic Zymes
ArcticZymes Technologies, Jethro Holter (CEO)
Wednesday September 2, 2020 14:00 - 14:30 CEST Room 1
InDex Pharmaceuticals
Index Pharmaceuticals, Peter Zerhouni (CEO)
Wednesday September 2, 2020 13:30 - 14:00 CEST Room 2
Calliditas Therapeutics
Calliditas Therapeutics, Renee Aguiar-Lucander (CEO)
Wednesday September 2, 2020 08:30 - 09:00 CEST Room 2
Implantica
Implantica, Peter Forsell (CEO & Founder)
Wednesday September 2, 2020 11:30 - 12:00 CEST Room 1